Publication | Closed Access

Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5

Active InhibitorFibrosisHeart FailureCardiomyopathyCardiovascular DiseaseMedicinePhysiologyCardiovascular PharmacologyPathologyCardiac FibrosisPharmacologyCardiologyAttenuated DevelopmentCardiac Pathology